Multi-center study on prediction of response to cetuximab-based therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma

Not Applicable

• Conditions: Recurrent/metastasis head and neck squamous cell carcinoma

• Registration Number: JPRN-UMIN000029903
• Lead Sponsor: Saitama Medical University International Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-11-09
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

Not provided

Exclusion Criteria

Patient who can not obtain consent for this study.

Study & Design

• Study Type: Observational
• Study Design: Not specified